Top Women Lawyers
May 14, 2015
Judith A. Hasko
Latham & Watkins LLP Menlo Park
Corp. that is likely the largest early clinical deal in biotech history.
The biotechnology companies agreed to jointly develop and commercialize up to six
anti-cancer stem cell product candidates from OncoMed's biologics pipeline, among
other therapeutics. With a potential total value of $3.3 billion, the deal includes
...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In